Catalyst Wire Dossier Catalyst Wire Dossier

Sofosbuvir + Ribavirin

sofosbuvir; ribavirin · Gilead Sciences
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sofosbuvir + Ribavirin, covering 2018-08-08 to 2019-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Sofosbuvir + Ribavirin in Adolescents and Children With Genotype 2 or 3 Chronic HCV Infection [Phase 2]

See pricing